245 related articles for article (PubMed ID: 20193119)
1. TGF-beta1 in serum and induced sputum for predicting radiation pneumonitis in patients with non-small cell lung cancer after radiotherapy.
Wang J; Qiao XY; Lu FH; Zhou ZG; Song YZ; Huo JJ; Liu X
Chin J Cancer; 2010 Mar; 29(3):325-9. PubMed ID: 20193119
[TBL] [Abstract][Full Text] [Related]
2. Variations of circulating endothelial progenitor cells and transforming growth factor-beta-1 (TGF-β1) during thoracic radiotherapy are predictive for radiation pneumonitis.
Liu Y; Xia T; Zhang W; Zhong Y; Zhang L; Wang X; Yu H
Radiat Oncol; 2013 Jul; 8():189. PubMed ID: 23885707
[TBL] [Abstract][Full Text] [Related]
3. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
[TBL] [Abstract][Full Text] [Related]
4. Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.
Wang S; Campbell J; Stenmark MH; Zhao J; Stanton P; Matuszak MM; Ten Haken RK; Kong FS
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):615-621. PubMed ID: 28581403
[TBL] [Abstract][Full Text] [Related]
5. Relationship of serum levels of VEGF and TGF-β1 with radiosensitivity of elderly patients with unresectable non-small cell lung cancer.
Fu ZZ; Gu T; Fu BH; Hua HX; Yang S; Zhang YQ; Gao LM; Li P
Tumour Biol; 2014 May; 35(5):4785-9. PubMed ID: 24557540
[TBL] [Abstract][Full Text] [Related]
6. Cytokine plasma levels: reliable predictors for radiation pneumonitis?
Rübe CE; Palm J; Erren M; Fleckenstein J; König J; Remberger K; Rübe C
PLoS One; 2008 Aug; 3(8):e2898. PubMed ID: 18682839
[TBL] [Abstract][Full Text] [Related]
7. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
[TBL] [Abstract][Full Text] [Related]
8. [Correlations between Ape1/Ref-1, ICAM-1 and IL-17A Levels in Serum and Radiation Pneumonitis for Local Advanced Non-small Cell Lung Cancer Patients].
Guo L; Ding G; Xu W; Ge H; Jiang Y; Lu Y
Zhongguo Fei Ai Za Zhi; 2018 May; 21(5):383-388. PubMed ID: 29764588
[TBL] [Abstract][Full Text] [Related]
9. The TGF-beta1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients.
Kim JY; Kim YS; Kim YK; Park HJ; Kim SJ; Kang JH; Wang YP; Jang HS; Lee SN; Yoon SC
Radiat Oncol; 2009 Nov; 4():59. PubMed ID: 19943923
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients.
Novakova-Jiresova A; Van Gameren MM; Coppes RP; Kampinga HH; Groen HJ
Radiother Oncol; 2004 May; 71(2):183-9. PubMed ID: 15110452
[TBL] [Abstract][Full Text] [Related]
11. The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.
Zhao L; Sheldon K; Chen M; Yin MS; Hayman JA; Kalemkerian GP; Arenberg D; Lyons SE; Curtis JL; Davis M; Cease KB; Brenner D; Anscher MS; Lawrence TS; Kong FM
Lung Cancer; 2008 Feb; 59(2):232-9. PubMed ID: 17905467
[TBL] [Abstract][Full Text] [Related]
12. Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis.
Arpin D; Perol D; Blay JY; Falchero L; Claude L; Vuillermoz-Blas S; Martel-Lafay I; Ginestet C; Alberti L; Nosov D; Etienne-Mastroianni B; Cottin V; Perol M; Guerin JC; Cordier JF; Carrie C
J Clin Oncol; 2005 Dec; 23(34):8748-56. PubMed ID: 16314635
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of serum Ape1/Ref-1 combined with TGF-β1 monitoring in predicting the occurrence of radiation pneumonitis (RP) in non-small cell lung cancer patients.
Zhang Y; You H; Duan J; Gao Y
Ann Palliat Med; 2021 Mar; 10(3):3328-3335. PubMed ID: 33849117
[TBL] [Abstract][Full Text] [Related]
14. Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients.
Imano N; Kimura T; Kawahara D; Nishioka R; Fukumoto W; Kawano R; Kubo K; Katsuta T; Takeuchi Y; Nishibuchi I; Murakami Y; Horimasu Y; Masuda T; Fujitaka K; Hattori N; Nagata Y
Jpn J Clin Oncol; 2021 Dec; 51(12):1729-1735. PubMed ID: 34625805
[TBL] [Abstract][Full Text] [Related]
15. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
Piotrowski T; Matecka-Nowak M; Milecki P
Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
[TBL] [Abstract][Full Text] [Related]
16. [Correlation study of physical and biologic parameters to acute radiation pneumonitis].
Zhao YH; Li ZP; Chen XM; Liu XJ; Wu WC; Xu Y; Li P; Zhang JT; Zeng H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):796-800. PubMed ID: 19024317
[TBL] [Abstract][Full Text] [Related]
17. Changes of circulating transforming growth factor-beta1 level during radiation therapy are correlated with the prognosis of locally advanced non-small cell lung cancer.
Zhao L; Ji W; Zhang L; Ou G; Feng Q; Zhou Z; Lei M; Yang W; Wang L
J Thorac Oncol; 2010 Apr; 5(4):521-5. PubMed ID: 20130485
[TBL] [Abstract][Full Text] [Related]
18. [Study on the controlling effect of Shenqi Fuzheng injection on plasma cytokine network in patients with thoracic tumor undergoing radiotherapy].
Liu L; Ding Q; Dai XF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Dec; 27(12):1082-5. PubMed ID: 18198640
[TBL] [Abstract][Full Text] [Related]
19. Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan.
Zhao L; Wang L; Ji W; Wang X; Zhu X; Hayman JA; Kalemkerian GP; Yang W; Brenner D; Lawrence TS; Kong FM
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1385-90. PubMed ID: 19231104
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: a modeling study of dose dumping.
Vogelius IS; Westerly DC; Cannon GM; Mackie TR; Mehta MP; Sugie C; Bentzen SM
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):893-9. PubMed ID: 21477946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
